Royal Bank of Canada’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-82,900
Closed -$4.27M – 7753
2021
Q4
$4.27M Buy
82,900
+11,300
+16% +$554K ﹤0.01% 2501
2021
Q3
$3.54M Buy
+71,600
New +$3.88M ﹤0.01% 2591
2021
Q1
– Sell
-51,700
Closed -$2.77M – 7434
2020
Q4
$2.77M Hold
51,700
– – ﹤0.01% 2635
2020
Q3
$2.43M Buy
+51,700
New +$2.65M ﹤0.01% 2528
2015
Q4
– Sell
-220,000
Closed -$16.9M – 6639
2015
Q3
$16.9M Buy
220,000
+181,000
+464% +$15.1M 0.01% 852
2015
Q2
$3.26M Buy
+39,000
New +$3.44M ﹤0.01% 1901

Other funds holding CAH

Royal Bank of Canada's CAH Position: Q2 2026 in Review

Royal Bank of Canada reduced its Cardinal Health (CAH) stake by 18% in Q2 2026, selling an estimated $35.7M and leaving 780,931 shares worth $186M. The position accounts for 0.03% of the portfolio, ranked #475.

Royal Bank of Canada first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. The position peaked at $201M in Q1 2026. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Royal Bank of Canada held 780,931 shares of Cardinal Health worth $186M as of Q2 2026.
  • Royal Bank of Canada sold 171,755 Cardinal Health shares in Q2 2026, an estimated $35.7M.
  • Cardinal Health made up 0.03% of Royal Bank of Canada's portfolio in Q2 2026, its #475 holding.
  • Royal Bank of Canada first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
  • Royal Bank of Canada's Cardinal Health position peaked at $201M in Q1 2026.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.